Futura Medical PLC Notice of Results (1732G)
16 Marzo 2020 - 01:00AM
UK Regulatory
TIDMFUM
RNS Number : 1732G
Futura Medical PLC
16 March 2020
16 March 2020
Notice of Results 2019
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), a
pharmaceutical company developing a portfolio of innovative
products based on its proprietary, transdermal technology
DermaSys(R) and currently focused on sexual health and pain, will
announce its audited results for the year ended 31 December 2019 on
Wednesday, 1 April 2020.
James Barder, Chief Executive Officer, Angela Hildreth, Finance
Director/Chief Operating Officer, and Ken James, Executive Director
and Head of R&D, will host a webcast for analysts on the day of
the results, which will be made available within the investor
centre section of the Company's website.
In light of growing concerns regarding COVID-19, the Company has
decided to cancel its scheduled Investor Seminar, to be held on 26
March 2020.
The Results webcast will now incorporate the Investor Seminar
presentation which includes an extensive internal evaluation of the
clinical data from the Phase 3 study ("FM57"), ongoing research and
analysis of MED3000, as well as an update on regulatory discussions
and insight into the erectile dysfunction market presented by
Professor David Ralph, world leading expert in erectile dysfunction
and male infertility and member of the Futura European KOL Advisory
Panel.
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
Email: Investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
www.futuramedical.com
Nominated Adviser and Sole Broker:
Liberum
Bidhi Bhoma/ Euan Brown/ Kane Collings
Tel: +44 (0) 20 3100 2000
For media enquiries please contact:
Optimum Strategic Communications
Mary Clark/ Eva Haas/ Hollie Vile
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 950 9144
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORDXLFFBXLBBBQ
(END) Dow Jones Newswires
March 16, 2020 03:00 ET (07:00 GMT)
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024